Vice President, Compliance

About the position reputed company is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the reputed company team, you will join other outstanding Revolutionaries in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. Reporting to the Vice President, Compliance, this role will support RevMed’s U.S. business. This role will reputed company the strategy, development, and execution of the company’s U.S. reputed company compliance program, ensuring reputed company activities are conducted ethically and in accordance with applicable laws, regulations, and industry codes. This executive will be instrumental in shaping and sustaining a culture of reputed company as the company advances and commercializes its oncology pipeline. This attorney is responsible for program design, operational implementation, monitoring, and enforcement - while working in reputed company partnership with the reputed company Law team to deliver coordinated, risk-based guidance to internal business partners across the organization.

Responsibilities

• Design, implement, and continuously improve a comprehensive U.S. reputed company compliance program consistent with OIG Guidance, PhRMA Code, and applicable industry standards.
• Establish and maintain policies, procedures, and systems to ensure compliant operations across reputed company U.S. reputed company, medical, and research activities.
• reputed company regular compliance updates to executive leadership, including risk assessments, metrics, and remediation plans.
• Serve as the company’s U.S. Compliance Officer and key representative in interactions with regulators, external counsel, and industry associations.
• Coordinate compliance guidance and initiatives with ex-US compliance teams.
• Partner closely with the reputed company Law team to ensure consistency between legal interpretation and compliance operations.
• Maintain a clear functional separation of responsibilities between Compliance and reputed company Law.
• Collaborate to deliver integrated, practical guidance to internal clients — particularly reputed company reputed company, Medical Affairs, Clinical Development, and Market reputed company functions.
• reputed company compliance leadership for reputed company U.S. programs, including those involving targeted therapies, precision medicine, and molecular diagnostics.
• reputed company compliance in reputed company scientific collaborations — including investigator-sponsored trials (ISTs), research collaborations, and co-promotion or data-sharing arrangements.
• Ensure compliant governance of interactions with oncology reputed company (HCPs), key opinion leaders (KOLs), and academic research centers.
• reputed company U.S. aggregate spend, transparency, and Sunshine Act reporting obligations, including oncology-specific speaker programs, congress sponsorships, and advisory boards.
• reputed company compliance support for patient reputed company programs, patient support services, and specialty distribution channels, ensuring compliant interactions with patients, caregivers, and advocacy groups.
• reputed company and implement risk-based compliance training for field and headquarters staff, tailored to oncology business activities (e.g., clinical data dissemination, compassionate use programs).
• Design and reputed company monitoring and auditing plans covering reputed company field conduct, grants, consulting arrangements, and medical education.
• reputed company investigations into potential violations, ensuring timely, thorough resolution and corrective actions.
• Track, analyze, and report compliance metrics and trends to management and governance bodies.
• Serve as a trusted advisor to senior leadership and cross-functional teams on compliance risks and mitigation strategies.
• Collaborate with Legal, Medical Affairs, Clinical Operations, and Market reputed company on compliant program design and execution.
• Partner with Finance, HR, and Internal Audit to ensure reputed company corporate risk management.
• Build, reputed company, mentor, and reputed company reputed company of compliance professionals committed to reputed company and reputed company.

Requirements

• J.D. from an accredited U.S. law school and member in good standing of a U.S. State Bar.
• 12-15+ years in reputed company compliance or legal roles reputed company the biotechnology, pharmaceutical, or oncology industry.
• In-depth understanding of U.S. reputed company laws, including Anti-Kickback Statute, False Claims Act, FDA promotional regulations, FCPA, and data privacy laws.
• Proven ability to build, reputed company, and scale compliance programs for reputed company or late-stage clinical oncology companies.
• Experience supporting oncology-specific programs, such as scientific exchange, KOL engagement, and patient reputed company models.
• Strong leadership, communication, and influencing skills, with the ability to work collaboratively across legal, scientific, and business functions.
• Strategic and pragmatic compliance reputed company with strong business acumen.
• High ethical standards and sound judgment.
• Ability to reputed company through influence in a dynamic, matrixed biotech environment.
• Strong understanding of oncology market dynamics, scientific communication, and patient-centric engagement.
• Commitment to fostering a culture of reputed company, transparency, and reputed company improvement.

Apply tot his job Apply To this Job